Jeffrey Ecsedy, Ph.D.

Jeff Ecsedy has over 20 years of experience in cancer research. Most recently, Jeff served as the Head of Oncology Translational Medicine at Takeda Pharmaceuticals where he and his team led translational science for a diverse portfolio of molecules spanning all stages of development, including pre-IND activities, first-in-human studies, regulatory approvals and life-cycle management. As a member of Oncology R&D leadership at Takeda, Jeff helped to shape a renewed strategic vision for Takeda Oncology. Prior to that, Jeff led numerous projects from the discovery phase into clinical development at Millennium Pharmaceuticals. Jeff received a B.S. from the University of Connecticut, earned his Ph.D. in Biological Sciences at Boston College and trained as a post-doctoral fellow in Genetics at Harvard Medical School.